Correction to: Novel smac mimetic APG-1387 elicits ovarian cancer cell killing through TNF-alpha, Ripoptosome and autophagy mediated cell death pathway

In the publication of this article [1], there was an error in Figs. 2, 3 and 6.

In the Results, APG-1387 is RIP1-dependent in ovarian cancer induced apoptosis section there was an error: 'We examined the protein levels of caspase-8/RIP1 by western blot, as shown in Fig. 4a'.
Should instead read: 'We examined the protein levels of caspase-8/RIP1 by western blot. APG-1387 triggered the activation of caspase-8 and downregulated the protein level of RIP1, as shown in Fig. 4a'.
In the Results, APG-1387 induces apoptotic cell death through engagement of TNFR1 by TNF-alpha signaling pathway section there was an error: 'We have investigated the expression of NF-κB1/p50 and NF-κB2/p52 by western blot after cells were incubated with various concentrations of APG-1387'.
Should instead read: 'These results demonstrate that TNFα signaling is required for APG-1387-induced apoptotic cell death. Next, we have investigated the expression of NF-κB1/p50 and NF-κB2/p52 by western blot after cells were incubated with various concentrations of APG-1387'.
In the Discussion section there was an error: ' APG-1387 is a novel Smac mimetic. In our study, we investigated the molecular mechanisms underlying the inhibitory effect on the growth of ovarian cancer cell lines treated with varying concentrations of APG-1387'.
Should instead read: 'Restoring the apoptotic cell death machinery by pharmacological inhibition of IAPs proteins represents a compelling strategy for cancer therapy. APG-1387 is a novel Smac mimetic developed by Ascentage and currently being evaluated in phase I clinical trial. In our study, we investigated the in vitro and in vivo antitumor activity of APG-1387 in ovarian cancer'.
In the Discussion section there was an error: 'Our results suggest that APG-1387 induces autophagy during apoptosis. Autophagy plays a role in protecting cell survival. We have also found that it was effective as a single agent in vivo models. Treatment with APG-1387 induced potent cytotoxic and antiproliferative activity against established and human ovarian cancer cells'.
Should instead read: 'Our results suggest that APG-1387 induces autophagy while triggering apoptosis. APG-1387-induced autophagy plays a role in protecting cell survival and inhibition of autophagy potentiates cytotoxicity of APG-1387 in ovarian cancer cells'. This has now been updated in the original article [1]. Fig. 2 Effects of APG-1387 on apoptosis in ovarian cancer. a APG-1387 inhibited the proliferation of SKOV3 cell line. They were treated with the indicated concentrations of APG-1387 for 24, 48, 72 h. Cell viability was determined by the CCK-8 assay. b Morphology of SKOV3 cells exposed to APG-1387(0, 10 nM) photographed under a fluorescence microscope (original magnification× 10). c APG-1387induced apoptosis in SKOV3 cells was assessed by Hoechst33258 staining. Morphology of SKOV3 cells exposed to APG-1387 at different concentrations photographed under a fluorescence microscope (original magnification × 10). Condensated and fragmented nuclears were the mean ± SEM of 5 randomized areas. P < 0.01. d SKOV3 cells were treated with 10 nM APG-1387 for the indicated times. The cells were stained for phosphorylated H 2 AX and DAPI, then were analyzed by fluorescence microscopy (original magnification × 200). γ-H 2 AX positive spots were the mean ± SEM of 5 randomized areas. P < 0.01. e, f SKOV3 and OVCAR3 cells were exposed to various concentrations of APG-1387 (0, 10, 30 nM) for 24 h followed cell apoptosis analysis by flow cytometry. g Western blot analysis of caspase-3/PARP SKOV3 cells were treated withAPG-1387 (0, 3, 10, 30, 100, 300 nM) for 24 h. The data shown are representative of three different experiments. h SKOV3 cells were stimulated with APG-1387 for indicated periods of concentrations, caspase activation were tested by caspase activity assay  b Cells were transfected with GFP-LC3 plasmids, and then maintained in media with or without 3 nM APG-1387 for 24 h. The cells were then stained with DAPI and analyzed by fluorescence microscopy. c Statistical analysis of the percentage of LC3 puncta per cell. Columns, mean (n = 3); bars, SD. *P < 0.01 vs. untreated group. LC3 puncta per cell were quantified. d Cells were transfected with Beclin1 siRNAs. Western blot was used to detect the expression of Beclin1. e Cells were transfected with ATG7 siRNAs. Western blot was used to detect the expression of ATG7. f Cells were transfected with Beclin1 siRNAs. After 24 h treatment with or without 3 nM APG-1387, western blot analysis was performed for indicated proteins. g Cells were transfected with ATG7 siRNAs. After 24 h treatment with or without 3 nM APG-1387, western blot analysis was performed for indicated proteins. h Western blot analysis was performed for indicated proteins in cells transfected with siBeclin-1 and treated with 10 nM APG-1387. i Western blot analysis was performed for indicated proteins in cells transfected with siATG7-1 and treated with 10 nM APG-1387